Compare your options

CoreAge Rx review: the advertised price, full payment and renewal terms

Read CoreAge Rx’s public compounded-treatment offer alongside its consultation-fee, refund, shipping and subscription conditions in this company-published review.

By CoreAge Rx · Published · Updated · 5 min read

Published by CoreAge Rx. This is company-published educational and promotional content, not an independent review or third-party endorsement.

General education; individual care decisions require a licensed clinician. This article does not report a clinical review or study of CoreAge Rx patients.

The quick answer

CoreAge Rx’s checked product pages advertise compounded semaglutide from $79 per month and compounded tirzepatide from $129 per month. Confirm the complete payment and supply period at checkout. This website is published by CoreAge Rx; the review explains public terms and their limits without reporting independent patient testing or a verified satisfaction score.

Know who is describing the service

This website’s about page identifies CoreAge Rx as the publisher. The review evaluates the public offer as company-published information. We did not enroll as patients, contact a treating clinician on a patient’s behalf or audit the company’s financial or clinical records. Statements about a policy should therefore be read as statements of the published terms.

For another perspective on the business record, BBB’s profile lists an F rating, no accreditation and alerts as checked October 15, 2026. The linked account reports unresolved concerns about service and billing. We have not verified an individual complaint outcome or established that the issues were resolved. An updated advertising page does not establish a resolution.

The starting monthly figure is one part of the quote

The semaglutide offer shows a starting figure of $79 per month, while the tirzepatide offer shows $129. Both pages describe compounded products and advertise no membership fee and included delivery. Read the number with the exact selected product and payment term; the headline alone does not specify every possible checkout.

Ask for the amount charged today, the medication quantity covered and the date of the next charge. If an offer averages a longer purchase over several months, distinguish that average from a monthly installment. Our program-cost guide provides a framework for comparing the same period and services across programs. A lower monthly headline can still require a larger initial payment.

Clinical review can affect what is refundable

The current order policy states that an applicable consultation fee of $50–$100 can become non-refundable once provider review begins, including when treatment is not recommended. Ask whether that fee applies to the selected order and how it is handled if a refund is otherwise approved. “No membership fee” does not mean that every charge is refundable.

The distinction matters before paying, not only after a problem occurs. Clinical assessment is a service and a prescription is a possible outcome of that assessment. This review does not promise approval, a particular formulation or an unconditional refund when a clinician decides that the requested medicine is inappropriate.

Ending future billing differs from reversing an existing order

The policy describes both one-time purchases and subscriptions. For a subscription, it says to cancel before the renewal is processed to prevent future billing. It separately states that an order already approved by the provider and transmitted for pharmacy fulfillment may be final, including before the shipment has left the pharmacy.

The same policy states a 30-day refund cutoff measured from the original purchase, including incomplete orders held for missing documentation, except where applicable law requires otherwise. These are the company’s stated conditions; this article does not determine their legal enforceability. Save the policy version and written cancellation acknowledgment, and specify whether a request concerns a future renewal, a current order or both.

Do not start a delivery estimate at the payment timestamp

The order-policy timeline runs through intake, required documentation, provider review, pharmacy fulfillment and shipping. It describes an approximate five-to-seven-business-day order-completion period when information is supplied promptly, and a separate approximate two-to-three-business-day delivery period after shipment. Neither estimate establishes an unconditional arrival date for a particular order.

Ask which stage has been reached and which action is needed from you. A tracking label, a prescription approval and a completed intake represent different events. If a supply issue could interrupt treatment, contact the clinician about the care plan rather than changing the dose or borrowing instructions from another patient’s review.

Compare the product as well as the price

Compounded semaglutide or tirzepatide should not be presented as an FDA-approved generic version of an approved brand. FDA explains that compounded medicines are not approved and do not receive its premarket evaluation of safety, effectiveness and quality. Ask why the proposed preparation meets a medical need that an approved product cannot meet.

Patient stories about appetite or “food noise” do not establish which prescription is suitable. The food-noise and hunger guide helps describe those concerns without using an informal phrase as a diagnosis. A useful consultation also addresses health history, other medicines, possible harms and follow-up; a review cannot make that individual decision.

Keep a dated offer record before committing

Write down the total payment, supply period, renewal arrangement, relevant consultation fee and cancellation conditions together. Include the prescriber and dispensing pharmacy names when supplied, along with the route for clinical questions. A price comparison that omits a substantial condition is incomplete even if its arithmetic is correct.

Sources were checked October 15, 2026. This review does not rank customer satisfaction or establish that the company fulfilled an individual order as promised. Recheck the current offer and outside business record, and keep unanswered questions visible instead of treating the absence of a detail as a favorable term.

Common questions

Is $79 the full charge at every checkout?

No. It is the public starting monthly figure checked for semaglutide. The selected term, total due, supply and renewal conditions must be confirmed.

Does no membership fee mean there are no consultation-fee deductions?

No. The current policy separately describes applicable non-refundable provider consultation fees after review begins.

Does this review independently verify patient satisfaction?

No. CoreAge Rx publishes this website, and this article does not report an independently verified patient dataset.

Sources and fact-checking

Sources checked 2026-10-15. CoreAge Rx pages support descriptions of its service; medical and regulatory sources support the educational context. Offers and availability can change.

  1. CoreAge Rx: semaglutide offer
  2. CoreAge Rx: tirzepatide offer
  3. CoreAge Rx: order, refund and subscription policy
  4. FDA: concerns with unapproved GLP-1 drugs
  5. BBB: CoreAge Rx business profile